ANRX ADVANCE 80 mg x 30 Capsules – GenX Pharma

GenX Pharma ANRX ADVANCE 80 mg is a premium multi-compound research formulation combining LGD-4033 (Ligandrol), Andarine (S-4), MK-677 (Ibutamoren Mesylate), and Androsta-3,5-diene-7,17-dione (Arimistane) into a single advanced investigational product. Developed exclusively for laboratory research, this formulation enables scientists to investigate the interaction between androgen receptor signaling, growth hormone secretagogue pathways, steroid hormone metabolism, and endocrine regulation through complementary biological mechanisms.

By integrating two Selective Androgen Receptor Modulators (SARMs), a Growth Hormone Secretagogue Receptor (GHS-R1a) agonist, and an investigational steroidal aromatase-modulating compound, ANRX ADVANCE provides researchers with a comprehensive platform for studying androgen receptor activation, IGF-1 physiology, protein metabolism, gene transcription, steroid metabolism, cellular differentiation, and molecular endocrinology.

Each bottle contains 30 capsules, delivering a total of 80 mg of active ingredients per capsule, manufactured by GenX Pharma under stringent pharmaceutical-quality standards. Every batch undergoes rigorous quality testing to ensure exceptional purity, formulation consistency, and dependable laboratory performance.

Key Features

• Premium four-compound research formulation
• 80 mg total active ingredients per capsule
• 30 capsules per bottle
• Contains LGD-4033 (Ligandrol) – 15 mg
• Contains Andarine (S-4) – 25 mg
• Contains MK-677 (Ibutamoren Mesylate) – 15 mg
• Contains Androsta-3,5-diene-7,17-dione (Arimistane) – 25 mg
• High-purity laboratory-grade formulation
• Suitable for investigations involving androgen receptor biology, growth hormone physiology, steroid metabolism, endocrine signaling, protein metabolism, and molecular endocrinology
• Manufactured under rigorous pharmaceutical-quality standards
• Intended exclusively for laboratory and scientific research applications

How It Works

ANRX ADVANCE combines four investigational compounds with complementary biological mechanisms, enabling researchers to study multiple endocrine and metabolic pathways within a single laboratory model.

• LGD-4033 (Ligandrol) – 15 mg selectively binds to androgen receptors (AR), allowing investigations into protein metabolism, gene transcription, tissue-selective signaling, and musculoskeletal physiology.
• Andarine (S-4) – 25 mg is a selective SARM researched for its interaction with androgen receptors, making it valuable for studies involving receptor pharmacology, cellular differentiation, and skeletal muscle biology.
• MK-677 (Ibutamoren Mesylate) – 15 mg acts as a Growth Hormone Secretagogue Receptor (GHS-R1a) agonist, enabling investigations into growth hormone secretion, ghrelin receptor signaling, IGF-1 physiology, and endocrine communication.
• Androsta-3,5-diene-7,17-dione (Arimistane) – 25 mg is investigated for its role in steroid hormone metabolism and aromatase-related pathways, allowing researchers to examine endocrine regulation and steroidogenic processes.

Together, these complementary mechanisms provide researchers with a comprehensive platform for investigating androgen receptor biology, growth hormone signaling, steroid metabolism, receptor-ligand interactions, intracellular signaling, and molecular endocrinology in controlled laboratory environments.

This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.

Contents

Active Ingredients (Per Capsule):

• LGD-4033 (Ligandrol) – 15 mg
• Andarine (S-4) – 25 mg
• MK-677 (Ibutamoren Mesylate) – 15 mg
• Androsta-3,5-diene-7,17-dione (Arimistane) – 25 mg

Total Active Ingredients: 80 mg per capsule

Packaging: 30 Capsules